Typical costs related to Abnehmspritze Kinder

The question about typical costs of 'weight loss injections' (GLP-1 agonists like semaglutide, liraglutide) for children is sensitive. In the EU, liraglutide (Saxenda) is approved for adolescents aged 12+ with obesity, but only alongside lifestyle intervention. Monthly costs range from €200–350, but statutory health insurance in Germany usually does not cover it because it is considered off-label or lifestyle treatment. Private insurance may reimburse after individual review. Additional costs include medical supervision, lab tests, and possibly nutritional counseling. Importantly, long-term safety and efficacy data in children are limited; no completed long-term trials exist. These drugs are not marketed as 'kids' weight loss shots' but as diabetes or obesity therapies. Parents should be wary of offers promising rapid weight loss. Costs are high, benefits uncertain, and risks include nausea, pancreatitis, and gallbladder issues. Thorough medical consultation is essential before considering such therapy.